Refocus Group Inc RFCS:OTCPK

RT Quote | Exchange | USD
Last | 03/04/21 EST
0.042UNCH (UNCH)
52 week range
0.02 - 0.28

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.042
  • 52 Week High0.28
  • 52 Week High Date11/09/20
  • 52 Week Low0.02
  • 52 Week Low Date12/02/20
  • Market Cap1.04M
  • Shares Out24.67M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • 1 Year % Change-44

RATIOS/PROFITABILITY

  • EPS (TTM)-0.20
  • P/E (TTM)-0.21
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-4.42M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Refocus Group Inc News

There is no recent news for this security.

Latest RFCS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Refocus Group, Inc. is a medical device company. The Company is engaged in the research and development of treatments for human vision disorders. The Company's VisAbility is a medical device, which is designed to improve near vision that is performed in both eyes. The Company's treatment for presbyopia can restore the natural ability to focus at near and intermediate distances, without considering the distance vision. The Company's VisAbility Micro-Inserts are...
Glen Bradley Ph.D.
Chairman
Douglas Williamson
Chief Executive Officer
Zack Thompson
Chief Financial Officer
Mark Cox
Chief Financial Officer
Address
10210 N Central Expy Ste 400
Dallas, TX
75231-3471
United States